Qube Research & Technologies Ltd - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 35 filers reported holding SIGILON THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$5,000
-44.4%
10,159
-10.2%
0.00%
Q2 2022$9,000
-98.7%
11,308
-19.6%
0.00%
-100.0%
Q4 2020$676,00014,0680.01%
Other shareholders

There were no reported owners of SIGILON THERAPEUTICS INC in Q3 2022.

NameSharesValueWeighting ↓
View complete list of SIGILON THERAPEUTICS INC shareholders